Cookies disclaimer

Estoy de acuerdo utilizamos cookies para mejorar la experiencia de navegación del usuario y para estudiar cómo se utiliza nuestro sitio web. si navega por nuestro sitio web, estará aceptando el uso de las cookies en las condiciones establecidas en la presente política de cookies. esta política puede ser actualizada, por lo que le invitamos a revisarla de forma regular

84625-61-6 - Itraconazole, 98% - Oriconazole - R51211 - J66390 - Alfa Aesar

J66390 Itraconazole, 98%

Número CAS
84625-61-6
Nombre Alternativo
Oriconazole
R51211

Tamaño Precio ($) Cantidad Disponibilidad
1g 71,40
5g 143,00
25g 608,00
Añadir al carrito Añadir al presupuesto al por mayor Ver artículo

Itraconazole, 98%

MDL
MFCD00870168

Propiedades químicas

Fórmula
C35H38Cl2N8O4
Peso molecular
705.63
Formulario
Powder
Punto de fusión
166°
Punto de inflamabilidad
>110°(230°F)
Solubilidad
Insoluble in water. Solube in chloroform at 50 mg/ml. Slightly soluble in ethanol or methanol

Aplicaciones

Itraconazole is a triazole antifungal agent. It is used to inhibit cytochrome P-450-dependent enzymes and ergosterol synthesis. It has been used against histoplasmosis, blastomycosis, cryptococcal meningitis, and aspergillosis. It?s different formulations are used to study Candida strains in murine invasive infections. It has been used to study proliferative changes of the forestomach mucosa in alloxan-induced diabetic rats..

Notas

Research Use only: Not intended for animal or human diagnostic or therapeutic use.

Referencias documentales

Katsuhisa Uchida; Kosuke Shimogawara; Hideyo Yamaguchi. Correlation of in vitro activity and in vivo efficacy of itraconazole intravenous and oral solubilized formulations by testing Candida strains with various itraconazole susceptibilities in a murine invasive infection. Journal of Antimicrobial Chemotherapy.2011, 66, (3), 626-634.

Tomoya Sano; Kiyokazu Ozaki; Yasushi Kodama; Tetsuro Matsuura; Isao Narama. Effects of the antifungal agent itraconazole on proliferative changes of the forestomach mucosa in alloxan-induced diabetic rats. Toxicologic Pathology.2009, 37, (6), 790-798.

Indicaciones de peligro y de precaución del GHS

Indicaciones de peligro (UE): H315-H319-H335

Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation.

Indicaciones de precaución: P261-P280-P305+P351+P338-P304+P340-P362-P312-P321-P405-P403+P233-P501a

Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Take off contaminated clothing and wash before reuse. Call a POISON CENTER or doctor/physician if you feel unwell. Specific treatment (see label). Store locked up. Store in a well-ventilated place. Keep container tightly closed. Dispose of contents/container in accordance with local/regional/national/international regulations.

Otras referencias

Merck
14,5245
Código de tarifa arancelaria unificado
2941.90
TSCA
No
RTECS
XZ5481000

Recomendado

Visto recientemente

Productos químicos

Ciencias de la vida

Metales & materiales

Catalizadores

Análisis y material de laboratorio